Literature DB >> 8730257

Gastric mucosal inflammatory responses to Helicobacter pylori.

J E Crabtree1.   

Abstract

Within the gastroduodenal mucosa Helicobacter pylori infection stimulates local production of a range of proinflammatory and immunoregulatory cytokines, neutrophil infiltration, specific T- and B-cell responses and the development of gastric lymphoid follicles. Following bacterial eradication this mucosal inflammatory response resolves. Infiltrating neutrophils are likely to be one of the major mediators of mucosal damage. Neutrophil activation, including reactive oxygen metabolite production and the release of myeloperoxidase, will be induced directly by bacterial factors and indirectly through products of complement activation, bioactive lipids and host-derived cytokines. Interleukin-8, and related peptides of the chemokine family secreted by gastric epithelial cells, are likely to be important host mediators inducing neutrophil migration to sites of infection. Epithelial IL-8 is upregulated by TNF-alpha and IL-1 and directly by H. pylori strains expressing the CagA phenotype. The extent of mucosal injury may reflect bacterial density, the variability of different strains of H. pylori to induce chemokine expression in epithelial cells and the oxidative burst in neutrophils. Recent evidence from in vivo and in vitro studies shows that CagA+ VacA+ strains of H. pylori are associated with enhanced inflammatory responses and mucosal damage. Defining the specific bacterial mediators of mucosal inflammation will be important in elucidating the role of H. pylori in the pathogenesis of gastroduodenal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730257     DOI: 10.1046/j.1365-2036.1996.22164003.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  38 in total

1.  Validation of serological tests for Helicobacter pylori infection in an Irish population.

Authors:  N P Breslin; J M Lee; M J Buckley; E Balbirnie; D Rice; C A O'Morain
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

3.  Mucosal lymphocyte subsets and HLA-DR antigen expression in paediatric Helicobacter pylori-associated gastritis.

Authors:  A I Lopes; R M M Victorino; A M Palha; J Ruivo; A Fernandes
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

4.  Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation?

Authors:  N Figura; F Cetta; M Angelico; G Montalto; D Cetta; L Pacenti; C Vindigni; D Vaira; F Festuccia; A De Santis; G Rattan; R Giannace; S Campagna; C Gennari
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

5.  Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.

Authors:  H Kim; J Y Seo; K H Kim
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

6.  Cytokine expression in pediatric Helicobacter pylori infection.

Authors:  Ana I Lopes; Marianne Quiding-Jarbrink; Ana Palha; José Ruivo; Lurdes Monteiro; Mónica Oleastro; Andrea Santos; Afonso Fernandes
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

7.  Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.

Authors:  R Carratù; D Iuliano; M R Iovene; F Ferraraccio; P Esposito; M I Russo; F Montella; G Abbate; M A Tufano
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

8.  Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility.

Authors:  Masafumi Ota; Tomomitsu Tahara; Toshimi Otsuka; Wu Jing; Tomoe Nomura; Ranji Hayashi; Takeo Shimasaki; Masakatsu Nakamura; Tomoyuki Shibata; Tomiyasu Arisawa
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

9.  Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis.

Authors:  M Bajaj-Elliott; P Fedeli; G V Smith; P Domizio; L Maher; R S Ali; A G Quinn; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Cellular mucosal defense is attenuated with chronicity of Helicobacter pylori infection.

Authors:  Geoffrey M Matthews; David Tivey; Adrian G Cummins; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.